Related Experiment Videos
Vascular permeability increasing factor (VPF) in IgA nephropathy
Abstract:
Peripheral blood mononuclear cells (PBC) from non-nephrotic and nephrotic patients with different glomerulopathies were tested for their potential to produce vascular permeability increasing factor (VPF) after stimulation with Concanavalin-A (Con-A) in vitro. Supernatants from cultures of PBC from patients with IgA nephropathy were injected intradermally into the skins of normal Wistar rats which were given Evans blue dye solution intravenously. The mean extravasation of dye after 60 minutes was taken as a standard for the induction of local vascular permeability. Using a routine vascular permeability assay based on this principle similar studies were done with supernatants from cultures of PBC from nephrotic subjects with minimal change disease (MCD), or membranous nephropathy (MGN) and from healthy donors. The results show that cultures of PBC from non-nephrotic subjects with IgA nephropathy as well as from nephrotic MCD patients produced VPF in their supernatants whereas lymphocytes from nephrotic MGN subjects or normal donors did not. It is concluded that the production of VPF in stimulated PBC cultures from patients with IgA nephropathy or MCD might reflect altered T-cell function in these diseases, and that there is no direct relationship between VPF production and increased glomerular permeability.
Insights
Peripheral blood mononuclear cells from IgA nephropathy and minimal change disease patients produced vascular permeability increasing factor (VPF). This suggests altered T-cell function, not a direct link to glomerular permeability.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Glomerulopathies are kidney diseases affecting the glomeruli.
- Vascular permeability increasing factor (VPF) is implicated in vascular changes.
- Altered immune cell function may contribute to kidney disease pathogenesis.
Purpose of the Study:
- To investigate the in vitro production of VPF by peripheral blood mononuclear cells (PBC) from patients with various glomerulopathies.
- To determine if VPF production correlates with disease state (nephrotic vs. non-nephrotic) or specific kidney conditions.
- To explore potential links between VPF production and T-cell function in IgA nephropathy and minimal change disease.
Main Methods:
- Peripheral blood mononuclear cells (PBC) were isolated from patients with IgA nephropathy, minimal change disease (MCD), membranous nephropathy (MGN), and healthy donors.
- PBC were stimulated in vitro with Concanavalin-A (Con-A).
- Vascular permeability was assessed in vivo using an Evans blue assay in Wistar rats injected with cell culture supernatants.
Main Results:
- Stimulated PBC from non-nephrotic IgA nephropathy patients and nephrotic MCD patients produced VPF.
- PBC from nephrotic membranous nephropathy (MGN) patients and healthy donors did not produce VPF.
- VPF production was observed in vitro, but no direct relationship was found between VPF and increased glomerular permeability.
Conclusions:
- VPF production by stimulated PBC in IgA nephropathy and MCD may indicate altered T-cell function in these conditions.
- The study differentiates VPF production from direct glomerular permeability in these nephrotic syndromes.
- Further research into T-cell dysregulation in glomerulopathies is warranted.